Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
Blood|March 18, 2020
Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantationSteffen Boettcher, C Matthias Wilk, Jochen Singer, et al.
Swiss Medical Weekly|April 5, 2024
Historic characteristics and mortality of patients in the Swiss Amyloidosis RegistrySofie Brouwers, Raphael Heimgartner, Natallia Laptseva, et al.
Nature Communications|November 28, 2019
Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selectionFrancisco Caiado, Diogo Maia-Silva, Carolina Jardim, et al.
Leukemia|May 7, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosisAnne Kaiser, Veronika Lysenko, Renier Myburgh, et al.
Frontiers in Immunology|January 1, 2024
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse modelsYasuyuki Saito, Rie Iida-Norita, Tania Afroj, et al.
Blood|September 2, 2016
inv(16) and NPM1mut AMLs engraft human cytokine knock-in miceJana M Ellegast, Philipp J Rauch, Larisa V Kovtonyuk, et al.
Nature Chemistry|April 9, 2021
Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applicationsNicholas Favalli, Gabriele Bassi, Christian Pellegrino, et al.
Blood|October 16, 2009
In vitro-differentiated T/natural killer-cell progenitors derived from human CD34+ cells mature in the thymusBob Meek, Silvie Cloosen, Chiara Borsotti, et al.
Haematologica|November 10, 2018
The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14Beatrice Drexler, Jakob R Passweg, Alexandar Tzankov, et al.
Blood|January 6, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germline ERCC6L2 diseaseRoman Schimmer, Nancy Klemm, Jonas Fullin, et al.
Pageof 26